Ausgabe 9/2011
Inhalt (23 Artikel)
PET imaging for prediction of response to therapy and outcome in oesophageal carcinoma
Sue Chua, John Dickson, Ashley M. Groves
Baseline 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer
Mathieu Hatt, Dimitris Visvikis, Olivier Pradier, Catherine Cheze-le Rest
18F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study
Sheng-Chieh Chan, Hung-Ming Wang, Tzu-Chen Yen, Chien-Yu Lin, Shy-Chyi Chin, Chun-Ta Liao, Yau-Yau Wai, Jiun-Jie Wang, Shu-Hang Ng
Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin’s disease
Egesta Lopci, Roberta Burnelli, Luca Guerra, Angelina Cistaro, Arnoldo Piccardo, Pietro Zucchetta, Enrico Derenzini, Alessandra Todesco, Alberto Garaventa, Fabio Schumacher, Piero Farruggia, Salvatore Buffardi, Alessandra Sala, Fiorina Casale, Paolo Indolfi, Samanta Biondi, Andrea Pession, Stefano Fanti
Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer
Wei Huang, Tao Zhou, Li Ma, Hongfu Sun, Heyi Gong, Juan Wang, Jinming Yu, Baosheng Li
Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies
Floris H. P. van Velden, Patsuree Cheebsumon, Maqsood Yaqub, Egbert F. Smit, Otto S. Hoekstra, Adriaan A. Lammertsma, Ronald Boellaard
123I-MIBG scintigraphy/SPECT versus 18F-FDG PET in paediatric neuroblastoma
Henriette Ingrid Melzer, Eva Coppenrath, Irene Schmid, Michael H. Albert, Dietrich von Schweinitz, Coral Tudball, Peter Bartenstein, Thomas Pfluger
Molecular imaging with 68Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours
Daniel Kaemmerer, Luisa Peter, Amelie Lupp, Stefan Schulz, Jörg Sänger, Vikas Prasad, Harshad Kulkarni, Sven-Petter Haugvik, Merten Hommann, Richard Paul Baum
Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)
Anna Sowa-Staszczak, Dorota Pach, Robert Chrzan, Małgorzata Trofimiuk, Agnieszka Stefańska, Monika Tomaszuk, Maciej Kołodziej, Renata Mikołajczak, Dariusz Pawlak, Alicja Hubalewska-Dydejczyk
Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapy
Giampiero Giovacchini, Guillaume Nicolas, Heike Freidank, Thomas L. Mindt, Flavio Forrer
Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl
Helge Hebestreit, Johannes Biko, Valentina Drozd, Yuri Demidchik, Antje Burkhardt, Andreas Trusen, Meinrad Beer, Christoph Reiners
Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions
Matthias Eiber, Axel Martinez-Möller, Michael Souvatzoglou, Konstantin Holzapfel, Anja Pickhard, Dennys Löffelbein, Ivan Santi, Ernst J. Rummeny, Sibylle Ziegler, Markus Schwaiger, Stephan G. Nekolla, Ambros J. Beer
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls
Henryk Barthel, Julia Luthardt, Georg Becker, Marianne Patt, Eva Hammerstein, Kristin Hartwig, Birk Eggers, Bernhard Sattler, Andreas Schildan, Swen Hesse, Philipp M. Meyer, Henrike Wolf, Torsten Zimmermann, Joachim Reischl, Beate Rohde, Hermann-Josef Gertz, Cornelia Reininger, Osama Sabri
Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression
Raphaelle Richieri, Laurent Boyer, Jean Farisse, Cecile Colavolpe, Olivier Mundler, Christophe Lancon, Eric Guedj
The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma
Michael Sørensen, Kim Frisch, Dirk Bender, Susanne Keiding
One-step radiosynthesis of 18F-AlF-NOTA-RGD2 for tumor angiogenesis PET imaging
Shuanglong Liu, Hongguang Liu, Han Jiang, Yingding Xu, Hong Zhang, Zhen Cheng
Is bone marrow uptake of 86Y-DOTATOC routinely observed?
Stephan Walrand, Stanislas Pauwels, François Jamar
90Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT)
Michael Wissmeyer, Susanne Heinzer, Pietro Majno, Franz Buchegger, Habib Zaidi, Valentina Garibotto, Magalie Viallon, Christoph D. Becker, Osman Ratib, Sylvain Terraz
Lymphoscintigraphy and SPECT/CT using 99mTc filtered sulphur colloid in chylothorax
Nathalie Prevot, Olivier Tiffet, John Avet Jr, Elske Quak, Marielle Decousus, Francis Dubois
EANM TG/C activity matrix 11/2010 – 10/2011
Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis
Florent L. Besson, Jean-Jacques Parienti, Boris Bienvenu, John O. Prior, Sylvie Costo, Gerard Bouvard, Denis Agostini
18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis
Hiroshi Ohira, Ichizo Tsujino, Keiichiro Yoshinaga